Evidence map›Paper›PMID 36512641›Full record

ArticleScience signaling2022

Stress signaling boosts interferon-induced gene transcription in macrophages.

Laura Boccuni, Elke Podgorschek, Moritz Schmiedeberg, Ekaterini Platanitis, Peter Traxler, Philipp Fischer, Alessia Schirripa, Philipp Novoszel, Angel R Nebreda, J Simon C Arthur and 8 more

Abstract read
In one paragraph

Article in Science signaling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Immunology of Stress: A Review Article.Journal of clinical medicine · 2024
    Review
  15. Transcriptional control of interferon-stimulated genes.The Journal of biological chemistry · 2024
    Review
  16. Article
  17. Article
  18. Interferon-Science (New York, N.Y.) · 2024
    Review
  19. Type I IFN in Glomerular Disease: Scarring beyond the STING.International journal of molecular sciences · 2024
    Review
  20. A Combination of Four Nuclear Targeted Effectors ProtectsbioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Laura BoccuniMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna 1030, Austria.ORCID 0000-0002-3229-4520
Elke PodgorschekMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna 1030, Austria.ORCID 0000-0002-5511-8984
Moritz SchmiedebergMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna 1030, Austria.
Ekaterini PlatanitisMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna 1030, Austria.ORCID 0000-0002-3371-2819
Peter TraxlerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria.ORCID 0000-0003-0373-8839
Philipp FischerMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna 1030, Austria.ORCID 0000-0002-6675-0571
Alessia SchirripaInstitute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna 1210, Austria.ORCID 0000-0001-5446-9136
Philipp NovoszelCenter for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.ORCID 0000-0002-1398-9140
Angel R NebredaInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Barcelona 08028, Spain.ORCID 0000-0002-7631-4060
J Simon C ArthurDivision of Cell Signaling and Immunology and University of Dundee, Dow Street, Dundee DD1 5EH, UK.ORCID 0000-0002-8135-1958
Nikolaus FortelnyCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria.ORCID 0000-0003-4025-9968
Matthias FarlikCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria.ORCID 0000-0003-0698-2992
Veronika SexlInstitute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna 1210, Austria.ORCID 0000-0001-9363-0412
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria.ORCID 0000-0001-6091-3088
Maria SibiliaCenter for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.ORCID 0000-0001-6129-5613
Pavel KovarikMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna 1030, Austria.ORCID 0000-0003-2956-0944
Mathias MüllerInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna 1210, Austria.
Thomas DeckerMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna 1030, Austria.ORCID 0000-0001-9683-0620
University of Vienna · ATAustrian Academy of Sciences · ATUniversity of Veterinary Medicine Vienna · ATComprehensive Cancer Center Vienna · ATInstitució Catalana de Recerca i Estudis Avançats · ESUniversity of Dundee · GB

Funding

Austrian Science Fund FWF P 33000Austrian Science Fund FWF W 1261
6 · The paper itself

Abstract

Promoters of antimicrobial genes function as logic boards, integrating signals of innate immune responses. One such set of genes is stimulated by interferon (IFN) signaling, and the expression of these genes [IFN-stimulated genes (ISGs)] can be further modulated by cell stress-induced pathways. Here, we investigated the global effect of stress-induced p38 mitogen-activated protein kinase (MAPK) signaling on the response of macrophages to IFN. In response to cell stress that coincided with IFN exposure, the p38 MAPK-activated transcription factors CREB and c-Jun, in addition to the IFN-activated STAT family of transcription factors, bound to ISGs. In addition, p38 MAPK signaling induced activating histone modifications at the loci of ISGs and stimulated nuclear translocation of the CREB coactivator CRTC3. These actions synergistically enhanced ISG expression. Disrupting this synergy with p38 MAPK inhibitors improved the viability of macrophages infected with

Indexed as

Interferon-gammaInterferonsMacrophagesp38 Mitogen-Activated Protein KinasesPhosphorylationSignal TransductionTranscription FactorsTranscription, GeneticInterferon-gammaInterferonsp38 Mitogen-Activated Protein KinasesTranscription Factors

Identifiers

PMID36512641
PMCPMC7619253
OpenAlexW4311314417

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.